I took the schedule off Curis' second quarter earnings release by going to its website and looking under "financials/information." In the written release, there is a section entitled "Upcoming Activities" and these presentations were listed. It said it "expects" to present at these conferences.
Thanks for posting this but I could only find information relative to the FBR conference in Boston, where can I find the info for the Baird conference? Also, I couldn't find Curis on the Bio Investor Forum's participating companie's list.
No volume on this stock, but should learn a lot over next four months; announcement of pivotal trial regarding refractory/relapsed DLBCL patients coupled with solid results regarding phase 1B at ASH in early December would make for a nice holiday. GO CRIS GO! Stay tuned for upcoming events:
Robert W. Baird & Co. 2015 Health Care Conference, September 9-10, 2015 in New York City
• FBR 2nd Annual Healthcare Conference, September 9, 2015 in Boston, MA
• 14th Annual BIO Investor Forum, October 20-21, 2015 in San Francisco
duckyah00, what do you have to gain with a message like this.. "Trash man..." Do you
1) get paid?
2) want inform others?
3) you have some personal issue with the company
4) just being helpful?
The Trash man forgot to throw this one out.
Market Makers are sitting with 20 million shares to pass on to innocent investors.
Plus CRIS has little prospect for success in the cure for Cancer.
Avoid this company like the plague.
Please identify the subtle signs. I bought a few shares yesterday, but was really just catching the proverbial falling knife. The volume on the move lower yesterday was anemic, so not convincing at all. Saw an article saying the downside at this point was minimal, but a possible double when it turns. I'm just looking for 20% or so on yesterday's buy, then have some other longer term shares.
Ducky shows his stupidity shorting CRIS twice at $3.57?
And KenBigBee is smart holding CRIS long?
Numbers speak louder than words.
As a long time holder and a short time seller.
I see an obsolete pipeline.
Tons of shares held by Broker bankers and institutions that are locked in.
No future revenue stream.
Just announced reduced research and development expenses.
Need to sell 10 million shares often.
Large debt with high interest expenses to pay down.
And a slow cash burn out rate of under 2 years.
Best to unwind before the big money does window dressing at the end of the Q?
As a long time stock holder of Curis - I would say a buyout is a very slim possibility. First Eagle would not allow it and they are the majority holder. However, I could see First Eagle taking Curis private if 907 is successful. This is only my opinion. GLTAL.
Take a look at the accumulation/distribution chart for the past few weeks. Also noticed that Barron's suggested them as a takeout target for CUDC-907.